glp-1 news october 9 2025 Regulating a "Miracle Drug": Costs, Access, & Safety The expanding landscape of GLP-1
Description
This move comes as these diabetes and weight-loss drugs see explosive demand in India, fueled by rising obesity rates and recent price reductions
Looking for more GLP-1 support
Supergut CEO Marc Washington on riding the Ozempic wave, the importance of prebiotic fibre, boosting GLP-1, and formulating vegan products.
Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects
Explore how GLP1s affect bone density and fracture risk
